CJC-1295 (No DAC)
CJC-1295 (No DAC) is a growth hormone releasing peptide used in evidence-based, physician-supervised protocols. Use for GH optimization, body recomposition, recovery, anti-aging, and sleep quality.
What is CJC-1295 (No DAC)?
Synthetic GHRH analogue (without Drug Affinity Complex). Stimulates pituitary GHRH-R to pulse GH release. Half-life ~30 min — produces physiological pulsatile GH pattern. Must be taken fasted (45 min before and after) to avoid insulin blunting GH pulse.
Uses & clinical decision logic
Use for GH optimization, body recomposition, recovery, anti-aging, and sleep quality. Pair with Ipamorelin for amplified, selective GH pulse.
CJC-1295 (No DAC) dosage & administration
| Vial size | BAC water | Dosing range | Units / dose | Frequency | Route |
|---|---|---|---|---|---|
| 5mg | 1mL | 200mcg-1mg | 4-20 units | 5 days on / 2 off | SubQ |
| 10mg | 2mL | 200mcg-1mg | 4-20 units | 5 days on / 2 off | SubQ |
Safety & contraindications
Avoid in active cancer (GH stimulation). Monitor IGF-1 levels.
Stacking & combinations
Classic pairing is CJC-1295 No DAC + Ipamorelin (synergistic GHRH + GHRP). Can add Sermorelin or Tesamorelin to stack.
Related peptides
Frequently asked questions
What is CJC-1295 (No DAC) used for?
Use for GH optimization, body recomposition, recovery, anti-aging, and sleep quality. Pair with Ipamorelin for amplified, selective GH pulse.
What is the typical CJC-1295 (No DAC) dosage?
Common dosing ranges from 200mcg-1mg (5 days on / 2 off, SubQ). Exact dosing is individualized and set by a licensed physician.
How is CJC-1295 (No DAC) administered?
CJC-1295 (No DAC) is typically administered via SubQ.
What are the contraindications for CJC-1295 (No DAC)?
Avoid in active cancer (GH stimulation). Monitor IGF-1 levels.
Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.
Build your protocol →This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.